About Parexel
Parexel is a Healthcare company based in Waltham (United States) founded in 1983, and was acquired by EQT in July 2021. Full-service clinical research organization services are provided globally by Parexel. Parexel has completed 14 acquisitions, including 3ClinicalResearch, Atlas Medical Services and California Clinical Trials. Its chief executive, as recorded, is Peyton Howell. Its website parexel.com draws about 221 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Celgene, Syneos Health and Medelis WCCT Global; 2 of its 3 listed competitors have raised funding.
Company details
Parexel International was founded in 1983 and is headquartered in Waltham, United States. Operations are conducted as a clinical research organization in the biopharmaceutical sector, with services encompassing clinical trials across phases I-IV, consulting on regulatory compliance and product development, informatics for data management, and access solutions for market entry and drug safety. Presence is maintained in 51 countries, supporting development of pharmaceuticals, biologics, medical devices, and biosimilars.
- InvestorsEQT
& 2 more
- Investments & Acquisitions3ClinicalResearch
& 13 more
- Acquired by
Associated legal entities of Parexel
Parexel is associated with 5 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Srias Life Spaces Llp CIN AAX-3008 | Active | 07 Jun 2021 | Hyderabad, Telangana | 6 | 4 | View details | |
| Heron Health Private Limited CIN U85100TS2007PTC190925 | Active | 21 Sep 2007 | Hyderabad, Telangana | ₹186 Cr | 775 | 2 | View details |
| Parexel International Services India Private Limited CIN U74900CH2014FTC035339 | Active | 26 Dec 2014 | Chandigarh, Chandigarh | ₹126 Cr | 884 | 4 | View details |
| Parexel International (India) Private Limited CIN U74999TG2006PTC051626 | Active | 11 Nov 2006 | Hyderabad, Telangana | ₹975 Cr | 3,107 | 4 | View details |
| Parexel International Clinical Research Private Limited CIN U74220KA2006PTC039077 | Active | 24 Apr 2006 | Bengaluru, Karnataka | ₹21.5 Cr | 74 | 4 | View details |
Apps and channels of Parexel
its YouTube channel Parexel International has 3.07K subscribers and 30 videos.
Videos from Parexel
The most watched videos on Parexel's YouTube channel, Parexel International (3.07K subscribers). Click a video to play it here.
More on Parexel International.
Investors in Parexel
Parexel has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include EQT, Goldman Sachs Asset Management and Pamplona Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
EQT is recognized as a global investment organization focused on value creation. | 1994 | eqtgroup.com | Stockholm, Sweden | |
Private equity investment firm focused on multiple sectors | pamplonafunds.com | London, United Kingdom | ||
Global asset management and investment solutions are provided. | 1989 | gsam.com | London, United Kingdom |
Investor details for Parexel
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Parexel
The boards of the 5 registered companies of Parexel currently have 10 directors; the longest-serving is Michael Francis Crowley Iii, appointed in 2017. 52 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Michael Francis Crowley Iii DIN 08029403 | Director | 20 Dec 2017 | 8 yrs 10 mo | Parexel International Services India Private Limited, Parexel International Clinical Research Private Limited, Parexel International (India) Private Limited |
| Sanjay Champalal Vyas DIN 08494946 | Director | 27 Jun 2019 | 7 yrs 4 mo | Parexel International Services India Private Limited, Parexel International Clinical Research Private Limited, Parexel International (India) Private Limited |
| Paul Joseph Armstrong DIN 08828392 | Director | 10 Aug 2020 | 6 yrs 3 mo | Parexel International Clinical Research Private Limited |
| Sureshkumar Reddy Parvathareddy DIN 02343804 | Designated Partner | 07 Jun 2021 | 5 yrs 5 mo | Srias Life Spaces Llp |
| Xavier Anne J Defourt DIN 08950913 | Director | 24 Apr 2023 | 3 yrs 6 mo | Heron Health Private Limited |
| Prameela Adapa DIN 10235973 | Director | 24 Jul 2023 | 3 yrs 3 mo | Heron Health Private Limited |
| John Ronald James Benoit DIN 10685026 | Director | 01 Jul 2024 | 2 yrs 4 mo | Parexel International Services India Private Limited, Parexel International Clinical Research Private Limited, Parexel International (India) Private Limited |
| Dasari Venkata Subba Reddy DIN 03086369 | Designated Partner | 25 Dec 2024 | 1 yr 10 mo | Srias Life Spaces Llp |
| Raja Kalyan Chakravarthy Uppuluri DIN 08321397 | Designated Partner | 25 Dec 2024 | 1 yr 10 mo | Srias Life Spaces Llp |
| Raja Kumar Kurra DIN 02240665 | Partner | 25 Dec 2024 | 1 yr 10 mo | Srias Life Spaces Llp |
People of Parexel
768 people are tracked at Parexel (322 in leadership, 446 in team).
| Name | Role | Group |
|---|---|---|
Peyton Howell | Chief Executive Officer | Leadership |
Helen Lingard | Vice President | Leadership |
Greg Rush | Executive Vice President and Chief Financial Officer | Leadership |
Noelia Javega | Senior Director, Project Leadership | Leadership |
Robin Morris | Project Director | Leadership |
Emily Heaps | Executive Director Talent Management And Organization Development | Leadership |
Sarah Daniels | Senior Director, Human Resources EMEA | Leadership |
Angela Hirst | Senior Director, Oncology Site Alliance Network | Leadership |
Pharm. Rodolfo M. Aiello | Associate Director - Portfolio Management | Leadership |
Kris Weldon | Executive Director, Project Leadership | Leadership |
Johnny Lancaster | General Manager | Leadership |
Gary Swartz | Associate Director - Decentralized Clinical Trials Solution Architect | Leadership |
Pei san Lim | Senior Director, Project Quality & Risk Management | Leadership |
Inga Schmeding | Senior Director, Project Leadership | Leadership |
Patrice Sullivan | Executive Director, Organizational Readiness | Leadership |
Ssu Wang | Executive Director, Talent Acquisition | Leadership |
Annemie Vanhoorne | Senior Director, Enterprise Clinical Operations Leaders, EMEA | Leadership |
Amy Pace | Vice President, Biostatistics | Leadership |
Rob Goodwin | Chief Operating Officer | Leadership |
Michelle Verhaeghe | Vice President, FSP Clinical Operations | Leadership |
748 more people are available in the full profile.
Complete people profiles for Parexel
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Parexel
Figures of Parexel International Services India Private Limited, the primary company behind Parexel, for FY 2026. Revenue was ₹126 Cr (-8% year on year). Net profit was ₹20.12 Cr (17% margin). EBITDA was ₹22.70 Cr (19% margin). Revenue has grown at a compounded annual rate of -7% over three years and -2% over five years.
- ₹126 CrRevenue · FY 2026 · -8% YoY
- ₹20.12 CrNet profit · 17% margin
- ₹22.70 CrEBITDA · 19% margin
- ₹40.49 CrPaid-up capital
- 884Employees (provident fund records)
- -7%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Parexel International Services India Private Limited are on its company page.
Detailed financial statements for Parexel
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Parexel
Parexel has strategically engaged in corporate development activities, having acquired 14 companies. Notable acquisitions include 3ClinicalResearch, Atlas Medical Services and California Clinical Trials.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Offers software solutions for pharmacovigilance, clinical research, and data analytics. | vitrana.com | Noida, India | 2014 | Apr 2026 | •••• | |
PK/PD modelling, simulation and analysis services | model-a.com.au | Brisbane, Australia | 2005 | Feb 2020 | •••• | |
Provider of medical affairs and consulting services to biopharma | themedicalaffairscompany.com | Kennesaw, United States | 2007 | Feb 2017 | •••• | |
Specialized CRO services are provided to pharma and biotech companies. | execupharm.com | King Of Prussia, United States | 2009 | Sep 2016 | •••• | |
Provider of strategic consulting services to healthcare and life sciences firms | healthadvances.com | Weston, United States | 1992 | Jan 2016 | •••• | |
Pharmacovigilance services are offered by Quantum Solutions as a CRO. | qsi.in | Chandigarh, India | 2004 | Mar 2015 | •••• | |
Cloud-based patient population and health management is offered to providers. | clinintell.com | Tampa, United States | 2011 | Oct 2014 | •••• | |
Clinical randomization and trial supply management services are provided. | clinintel.com | Crawley, United Kingdom | 2008 | Oct 2014 | •••• | |
CRO providing clinical research services for drug development | atlascro.com | Istanbul, Turkey | 2005 | Jul 2014 | •••• | |
Software services for life sciences regulatory processes are provided. | liquent.com | Horsham, United States | 1994 | Dec 2012 | $72M |
Complete acquisition details for Parexel
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Parexel
14 dated milestones of Parexel across 43 years, from founding to its latest funding, stage changes and deals.
- Founded Parexel is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Liquent.
- Acquisition Acquires Atlas Medical Services.
- Acquisition Acquires ClinIntel.
- Acquisition Acquires ClinIntell.
- Acquisition Acquires QSI.
- Acquisition Acquires Health Advances.
- Acquisition Acquires Execupharm.
- Acquisition Acquires The Medical Affairs Company.
- Exit Acquired by Pamplona Capital Management.
- Acquisition Acquires Model Answers.
- Exit Acquired by EQT.
- Acquisition Acquires Vitrana.
Competitors of Parexel
Parexel has 3 listed competitors in our database, 2 of them funded. They include Celgene, Syneos Health and Medelis WCCT Global.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. | ||
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. |
Detailed competitors of Parexel
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Parexel
The website of Parexel (parexel.com) receives about 220.8K visits a month and ranks #203,256 among all websites worldwide, #6,596 in Health.
- Monthly visits220.8K
▲ 6.2% vs previous month
- Unique visitors86.4K
per month
- Global rank#203,256
among all websites
- Category rank#6,596
Health · Health
- Bounce rate47%
- Pages per visit2.6
- Average visit1 min 04 sec
- DevicesDesktop 49% · Mobile 51%
Websites whose visitors overlap most with Parexel. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| quintiles.com | 100% | #377,823 | View details | ||
| bms.com | 83% | 809.8K | #67,210 | View details | |
| gsk.com | 82% | 1.3M | #56,834 | View details | |
| alcon.com | 82% | 171K | #286,128 | View details | |
| abbott.com | 82% | 917.2K | #65,577 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Parexel
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Parexel (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Parexel
Complete news archive for Parexel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parexel
Parexel was founded in 1983.
Parexel is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Peyton Howell is the CEO of Parexel, as recorded in our data.
Parexel International was founded in 1983 and is headquartered in Waltham, United States. Operations are conducted as a clinical research organization in the biopharmaceutical sector, with services encompassing clinical trials across phases I-IV, consulting on regulatory compliance and product development, informatics for data management, and access solutions for market entry and drug safety. Presence is maintained in 51 countries, supporting development of pharmaceuticals, biologics, medical devices, and biosimilars.
Parexel's top competitors include Syneos Health, Medelis WCCT Global and Celgene.
Parexel has made 14 acquisitions, including 3ClinicalResearch, Atlas Medical Services, and California Clinical Trials.
Parexel has 3 investors. Key investors include EQT, Goldman Sachs Asset Management, and Pamplona Capital Management.
Parexel is associated with 5 legal entities: Srias Life Spaces Llp, Parexel International Services India Private Limited, Heron Health Private Limited and others.
Yes. Parexel was acquired by EQT in July 2021.
The legal entities of Parexel currently have 12 directors, including Dasari Venkata Subba Reddy, Raja Kalyan Chakravarthy Uppuluri, Raja Kumar Kurra and others.
The website of Parexel receives about 221 thousand visits a month and ranks #203,256 among all websites worldwide.